Search

Your search keyword '"Regillo, Carl"' showing total 1,004 results

Search Constraints

Start Over You searched for: Author "Regillo, Carl" Remove constraint Author: "Regillo, Carl"
1,004 results on '"Regillo, Carl"'

Search Results

2. SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance

6. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

8. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

15. Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study

16. Brolucizumab—foreseeable workflow in the current scenario

17. Vortex vein anastomosis and pachychoroid—an evolving understanding

19. Scleral Buckle, Vitrectomy, or Combined Surgery for Inferior Break Retinal Detachment: Systematic Review and Meta-Analysis

20. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials

21. Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)

22. Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

23. Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression

24. Artificial Intelligence Detection of Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists’ Dilated Examinations

26. Risk Factors and Outcomes of Postoperative Macular Hole Formation after Vitrectomy for Myopic Traction Maculopathy: SCHISIS Report No. 2

27. RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby Syndrome

29. Retinal Displacement Following Rhegmatogenous Retinal Detachment Repair.

30. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.

31. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

32. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

34. Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases

35. Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel

37. TENAYA and LUCERNE

38. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

39. Faricimab Treat-and-Extend for Diabetic Macular Edema

43. Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal Diseases.

46. Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment

47. Scleral Buckle, Vitrectomy, or Combined Surgery for Inferior Break Retinal Detachment

48. Surgical Management of Full Thickness Macular Holes in Macular Telangiectasia Type 2.A Global Multicenter Study

Catalog

Books, media, physical & digital resources